Tagtociclib (PF-07104091): Mechanism of Action

Tagtociclib (PF-07104091) MOA:Targeting [CDK2]/[Cell Cycle Pathway] for [Hormone Receptor-Positive Breast Cancer]

🎯 check Tagtociclib (PF-07104091) product page

Tagtociclib is a competitive CDK inhibitor. It affects cell cycle signaling by blocking CDK-cyclin, inhibiting cell viability.

Primary Applications and Mechanism of Action